RET/PTC Rearrangement, Thyroid Cancer
Test Code
Clinical Significance
RET/PTC Rearrangement, Thyroid Cancer - RET/PTC gene fusion is detected in 5-40% of papillary thyroid carcinomas, but has been reported at low frequency in other types of thyroid lesions. Correlation with morphologic and clinical findings is thus required.
The assay tests for both RET/PTC1 and RET/PTC3 rearrangements using a reverse transcription PCR assay. The lower limit of sensitivity is approximately 2.5% mutation-bearing cells in a mixed sample, but can vary due to RNA preservation.
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Reference Range(s)
| RET/PTC1 | Not detected |
| RET/PTC3 | Not detected |
Alternative Name(s)
Preferred Specimen(s)
1 formalin-fixed, paraffin-embedded tissue block or needle washing
Minimum Volume
1 tissue block or needle washing
Collection Instructions
Do not reject. Needle washings in alcohol-based fixative (e.g. CytoLyt®) or formalin-fixed, paraffin-embedded tissue block FNA or FFPE specimens are acceptable for the assay.
All specimens must be accompanied with Pathology report. All FFPE specimens will be examined by a pathologist for confirmation and adequacy. Macrodissection if warranted is performed in the lab.
Transport Container
Paraffin-embedded tissue block
Transport Temperature
Room temperature
Specimen Stability
- FNA or FFPE
- Room temperature: 5 years
- Refrigerated: 5 years
- Frozen: Unacceptable
- Needle washings
- Room temperature: 30 days
- Refrigerated: 30 days
- Frozen: Unacceptable
Reject Criteria
Do not reject
Setup Schedule
All specimens must be accompanied with Pathology report. All FFPE specimens will be examined by a pathologist for confirmation and adequacy. Macrodissection if warranted is performed in the lab.
Room temperature: 5 years
Refrigerated: 5 years
Frozen: Unacceptable
Needle washings
Room temperature: 30 days
Refrigerated: 30 days
Frozen: Unacceptable